Dr. Chwastiak and Colleagues Reply
Authors:
- Lydia ChwastiakLCLydia Chwastiak
- Dawn M. EhdeDEDawn M. Ehde
- Laura E. GibbonsLGLaura E. Gibbons
- Mark SullivanMSMark Sullivan
- James D. BowenJBJames D. Bowen
- George H. KraftGKGeorge H. Kraft
- 1 August 2004
- journal article
- research article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 161 (8) , 1504
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Inhibitory Effect of Hippocampal 5-HT1A Receptors on Human Explicit MemoryAmerican Journal of Psychiatry, 2003
- Depressive Symptoms and Severity of Illness in Multiple Sclerosis: Epidemiologic Study of a Large Community SampleAmerican Journal of Psychiatry, 2002
- A study validating changes in the multiple sclerosis functional composite.Archives of Neurology, 2002
- Enhancement of Cognitive Performance in Schizophrenia by Addition of Tandospirone to Neuroleptic TreatmentAmerican Journal of Psychiatry, 2001
- The effect of tandospirone, a serotonin1A agonist, on memory function in schizophreniaBiological Psychiatry, 2001
- Recommendations from the national multiple sclerosis society clinical outcomes assessment task forceAnnals of Neurology, 1997
- Serotonin1A receptors are increased in postmortem prefrontal cortex in schizophreniaBrain Research, 1996
- The CES-D ScaleApplied Psychological Measurement, 1977